KDR and chronic obstructive pulmonary disease: However, we must point out the weakness of VEGFR2 as an indicator of angiogenesis progression because of its minimal variation in the BAL fluid and lung tissue between the two COPD groups that measured by the ELISA kits, as well as the lower expression level of VEGFR2 in lung tissue that tested by immunohistochemical analysis.